Lyell Immunopharma所有資訊

Lyell Immunopharma | 424B5：募資說明書

05/06 08:14 (美東)

Lyell Immunopharma | 10-Q：季度報表

05/06 08:09 (美東)

Lyell Immunopharma | 8-K：Lyell Immunopharma報告2024年第一季度的業務亮點和財務業績

05/06 08:03 (美東)

Lyell Immunopharma | EFFECT：其他

05/06 06:18 (美東)

Lyell Immunopharma | ARS：年度報告

04/22 16:22 (美東)

Lyell Immunopharma | DEFA14A：其他

04/22 16:22 (美東)

Lyell Immunopharma | DEF 14A：股東委託書決議

04/22 16:17 (美東)

Lyell Immunopharma | S-3：特定交易註冊聲明

02/29 13:35 (美東)

Lyell Immunopharma | S-8：員工福利計劃證券登記

02/29 13:35 (美東)

Lyell Immunopharma | 10-K：年度報表

02/28 22:28 (美東)

Lyell Immunopharma | 8-K：Lyell Immunopharma報告了2023年第四季度和全年業務亮點和財務業績

02/28 16:15 (美東)

Lyell Immunopharma | SC 13G/A：超過5%持股股東披露文件(修正)-ARCH Venture Fund IX, L.P.(14.5%),ARCH Venture Fund IX Overage, L.P.(14.5%)等

02/14 15:24 (美東)

Lyell Immunopharma | 4：持股變動聲明-高管 Lang Matthew

02/13 20:31 (美東)

Lyell Immunopharma | 4：持股變動聲明-高管 Hill Stephen J.

02/13 20:26 (美東)

Lyell Immunopharma | 4：持股變動聲明-高管 Lee Gary K.

02/13 20:26 (美東)

Lyell Immunopharma | 4：持股變動聲明-高管 Newton Charles W.

02/13 20:21 (美東)

Lyell Immunopharma | 4：持股變動聲明-高管 Seely Lynn

02/13 20:21 (美東)

Lyell Immunopharma | SC 13G/A：超過5%持股股東披露文件(修正)-The Vanguard Group(5.40%)

02/13 17:52 (美東)

Lyell Immunopharma | SC 13G：超過5%持股股東披露文件-BlackRock, Inc.(5.7%)

01/29 17:37 (美東)

Lyell Immunopharma | 4：持股變動聲明-首席財務官 Newton Charles W.

2023/11/20 20:55 (美東)